AVENUE THERAPEUTICS, INC. (OTC:ATXI)
Health Care/Life Sciences • Pharmaceuticals
CIK 1644963
Company
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Address
1111 Kane Concourse
Suite 301
Bay Harbor Islands, Florida 33154
1111 Kane Concourse
Suite 301
Bay Harbor Islands, Florida 33154
Employees
3
3
Stock Info
Close
$1.0000
$1.0000
Day Range
0.9602 - 1.0000
0.9602 - 1.0000
52 Week Range
0.9602 - 15.0000
0.9602 - 15.0000
Average volume
375.69K
375.69K
Short Interest
92.16K (02/14/25)
92.16K (02/14/25)
% of Float Shorted
5.31%
5.31%
Market Cap
$2.05M
$2.05M
Revenue
N/A
N/A
Net Income
-$10.38M
-$10.38M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director Alexandra MacLean |
Director Lindsay Allan Rosenwald |
Chairman Jay D. Kranzler |
Independent Director Faith L. Charles |
Independent Director Neil Herskowitz |
Independent Director Curtis G. Oltmans |
SEC filings
Date | Form | Event |
---|---|---|
4 Dec, 2024 | S-3 | |
3 Dec, 2024 | 4 | |
29 Nov, 2024 | 8-K | |
15 Nov, 2024 | SC 13D/A | |
14 Nov, 2024 | 10-Q | |
14 Nov, 2024 | 8-K | |
14 Nov, 2024 | SC 13G | |
7 Nov, 2024 | 4 | |
1 Oct, 2024 | 4 | |
27 Sep, 2024 | 8-K | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
25 Sep, 2024 | 4 | |
9 Aug, 2024 | 8-K | |
9 Aug, 2024 | 10-Q | |
12 Jul, 2024 | S-8 | |
26 Jun, 2024 | 8-K | |
23 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
15 May, 2024 | 8-K | |
13 May, 2024 | 8-K | |
10 May, 2024 | EFFECT | |
10 May, 2024 | 424B5 | |
10 May, 2024 | 424B3 | |
8 May, 2024 | UPLOAD | |
8 May, 2024 | CORRESP | |
6 May, 2024 | DEFA14A | |
6 May, 2024 | S-3 | |
6 May, 2024 | DEF 14A | |
2 May, 2024 | SC 13G/A | |
1 May, 2024 | 8-K | |
26 Apr, 2024 | 8-K | |
17 Apr, 2024 | 4 | |
17 Apr, 2024 | SC 13D/A | |
29 Mar, 2024 | 8-K | |
18 Mar, 2024 | 10-K | |
18 Mar, 2024 | 8-K | |
18 Mar, 2024 | DEF 14C | |
15 Mar, 2024 | 8-K | |
8 Mar, 2024 | 8-K | |
8 Mar, 2024 | PRE 14C | |
23 Feb, 2024 | 8-K | |
2 Feb, 2024 | 424B3 | |
1 Feb, 2024 | EFFECT | |
30 Jan, 2024 | CORRESP | |
29 Jan, 2024 | DEF 14C | |
29 Jan, 2024 | UPLOAD | |
24 Jan, 2024 | S-3 | |
17 Jan, 2024 | PRE 14C | |
12 Jan, 2024 | 8-K | |
8 Jan, 2024 | 8-K | |
3 Jan, 2024 | 4 | |
2 Jan, 2024 | SC 13G/A | |
13 Dec, 2023 | 4 | |
13 Dec, 2023 | SC 13G/A | |
28 Nov, 2023 | SC 13G | |
28 Nov, 2023 | 3 | |
24 Nov, 2023 | 8-K | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 424B4 | |
2 Nov, 2023 | 8-K | |
31 Oct, 2023 | EFFECT | |
30 Oct, 2023 | CORRESP | |
30 Oct, 2023 | CORRESP | |
27 Oct, 2023 | CORRESP | |
27 Oct, 2023 | CORRESP | |
24 Oct, 2023 | CORRESP | |
24 Oct, 2023 | CORRESP | |
24 Oct, 2023 | S-1/A | |
5 Oct, 2023 | FWP | |
4 Oct, 2023 | FWP | |
29 Sep, 2023 | S-1/A | |
28 Sep, 2023 | 8-K | |
27 Sep, 2023 | 8-K | |
21 Sep, 2023 | UPLOAD | |
18 Sep, 2023 | S-1 | |
18 Sep, 2023 | SC 13D/A | |
12 Sep, 2023 | 4 | |
12 Sep, 2023 | 4 | |
8 Sep, 2023 | 8-K | |
11 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
21 Jul, 2023 | 8-K | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 8-K | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 4 | |
5 Jul, 2023 | 4 | |
3 Jul, 2023 | 4 | |
28 Jun, 2023 | 424B3 | |
27 Jun, 2023 | EFFECT | |
26 Jun, 2023 | 8-K | |
23 Jun, 2023 | CORRESP | |
22 Jun, 2023 | UPLOAD | |
16 Jun, 2023 | S-3 | |
22 May, 2023 | 8-K | |
12 May, 2023 | 10-Q | |
12 May, 2023 | 8-K | |
4 May, 2023 | 424B3 | |
3 May, 2023 | EFFECT | |
1 May, 2023 | CORRESP | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | DEF 14A | |
17 Apr, 2023 | 8-K | |
17 Apr, 2023 | UPLOAD | |
11 Apr, 2023 | S-1 | |
4 Apr, 2023 | 4 | |
31 Mar, 2023 | 10-K | |
30 Mar, 2023 | 8-K | |
8 Mar, 2023 | 8-K | |
2 Mar, 2023 | 8-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | D | |
10 Feb, 2023 | S-8 | |
10 Feb, 2023 | 8-K | |
3 Feb, 2023 | 8-K | |
1 Feb, 2023 | 8-K | |
31 Jan, 2023 | 424B5 | |
25 Jan, 2023 | 8-K | |
17 Jan, 2023 | DEFA14A | |
6 Jan, 2023 | SC 13D/A | |
4 Jan, 2023 | DEFA14A | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | SC 13G | |
14 Dec, 2022 | SC 13G/A | |
18 Nov, 2022 | DEF 14A | |
18 Nov, 2022 | DEFA14A | |
10 Nov, 2022 | 10-Q | |
10 Nov, 2022 | 8-K | |
8 Nov, 2022 | PRE 14A | |
8 Nov, 2022 | 8-K | |
4 Nov, 2022 | 8-K | |
19 Oct, 2022 | SC 13D/A | |
18 Oct, 2022 | 8-K | |
17 Oct, 2022 | SC 13G | |
17 Oct, 2022 | SC 13G | |
13 Oct, 2022 | 4 | |
12 Oct, 2022 | 8-K | |
11 Oct, 2022 | 424B4 | |
6 Oct, 2022 | S-1/A | |
6 Oct, 2022 | EFFECT | |
6 Oct, 2022 | FWP | |
5 Oct, 2022 | S-1/A | |
5 Oct, 2022 | CORRESP | |
5 Oct, 2022 | CORRESP | |
30 Sep, 2022 | 8-K | |
22 Sep, 2022 | 8-K | |
2 Sep, 2022 | UPLOAD | |
31 Aug, 2022 | 8-K | |
31 Aug, 2022 | S-1 | |
22 Aug, 2022 | DEF 14C | |
15 Aug, 2022 | 10-Q | |
12 Aug, 2022 | 8-K | |
10 Aug, 2022 | PRE 14C | |
3 Aug, 2022 | 8-K | CEO Change |
3 Aug, 2022 | 3 | |
29 Jul, 2022 | 8-K | |
28 Jul, 2022 | SC 13D/A | |
25 May, 2022 | 3 | |
25 May, 2022 | 8-K | |
17 May, 2022 | 3 | |
16 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
13 May, 2022 | 8-K | |
5 Apr, 2022 | 8-K | |
30 Mar, 2022 | 8-K | CEO Change |
25 Mar, 2022 | 10-K | |
21 Mar, 2022 | 8-K | |
8 Mar, 2022 | 8-K | |
16 Feb, 2022 | 8-K | |
14 Feb, 2022 | SC 13G | |
11 Feb, 2022 | 8-K | |
9 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
7 Jan, 2022 | 8-K | CEO Change |
21 Dec, 2021 | 4 | |
21 Dec, 2021 | 3 | |
21 Dec, 2021 | 4 | |
21 Dec, 2021 | 4 | |
20 Dec, 2021 | 4 | |
20 Dec, 2021 | 4 | |
17 Dec, 2021 | S-8 | |
16 Dec, 2021 | 8-K | |
13 Dec, 2021 | 424B5 | |
13 Dec, 2021 | 8-K | |
10 Dec, 2021 | EFFECT | |
10 Dec, 2021 | 424B5 | |
9 Dec, 2021 | CORRESP | |
8 Dec, 2021 | UPLOAD | |
7 Dec, 2021 | S-3 | |
23 Nov, 2021 | DEF 14A | |
15 Nov, 2021 | 10-Q | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 424B5 | |
9 Nov, 2021 | 424B5 | |
4 Nov, 2021 | 8-K | |
25 Oct, 2021 | 8-K | |
1 Oct, 2021 | CORRESP | |
1 Oct, 2021 | EFFECT | |
30 Sep, 2021 | UPLOAD | |
28 Sep, 2021 | S-3 | |
21 Sep, 2021 | 8-K | |
15 Sep, 2021 | 4 | |
3 Sep, 2021 | 8-K | |
1 Sep, 2021 | 8-K | |
27 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q | |
29 Jul, 2021 | 8-K | |
15 Jul, 2021 | 8-K | |
14 Jun, 2021 | 8-K | |
17 May, 2021 | 10-Q | |
7 May, 2021 | 4 | |
3 May, 2021 | 8-K | |
5 Apr, 2021 | 8-K | |
31 Mar, 2021 | 10-K | |
1 Mar, 2021 | 8-K | |
16 Feb, 2021 | 8-K | |
12 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | SC 13G | |
8 Feb, 2021 | SC 13G | |
8 Jan, 2021 | 8-K |
Last update:2025-03-06 13:02:29.678365
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.